Investor mix
6 investors on record; lead investors include Novitas Capital, Burrill and Company, SV Health Investors, Novo Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Other / undisclosed | 2 | 33% |
Develops drugs that treat diseases associated with inflammation
6 investors on record; lead investors include Novitas Capital, Burrill and Company, SV Health Investors, Novo Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Other / undisclosed | 2 | 33% |